Dr. Harry P. Erba
Overview
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians.
Dr. Erba is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 137 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
20 Duke Medicine Cir, Durham, NC 27710
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Erba has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
University Of North Carolina At Chapel Hill
Brandi Reeves is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Reeves is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Multiple Myeloma, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Reeves is currently accepting new patients.
Duke Blood Cancer Center
I have the privilege of caring for patients with various myeloproliferative neoplasms including, polycythemia vera, essential thrombocytosis, primary myelofibrosis, systemic mastocytosis, and chronic myeloid leukemia. My goal is to provide the best possible care for each individual patient in an era where the number of therapeutic options for patients with myeloproliferative neoplasms is rapidly expanding. As a clinical investigator leading several clinical studies in both early and late stages of development, I strive to offer patients access to investigational agents with novel mechanisms of action via participation in clinical trials. I believe that every patient has a unique diagnosis and personal experience with their cancer. I aim to consider the disease, the patient and individual care goals in partnering with patients to develop and implement personalized treatment plans. Dr. Rein is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Systemic Mastocytosis, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.
Murat Arcasoy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Arcasoy is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Arcasoy is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- LeukemiaDr. Erba isElite. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Erba isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myelomonocytic LeukemiaDr. Erba isDistinguished. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Erba isDistinguished. Learn about Acute Promyelocytic Leukemia.
- Childhood Acute Myeloid LeukemiaDr. Erba isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Advanced
- Aplastic AnemiaDr. Erba isAdvanced. Learn about Aplastic Anemia.
- Ataxia-Pancytopenia SyndromeDr. Erba isAdvanced. Learn about Ataxia-Pancytopenia Syndrome.
- Bone Marrow AspirationDr. Erba isAdvanced. Learn about Bone Marrow Aspiration.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelomonocytic Leukemia (CMML)
- Experienced
- Acute Erythroid Leukemia (AEL)Dr. Erba isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Monoblastic Leukemia (AmoL)Dr. Erba isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AgranulocytosisDr. Erba isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Erba isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- AnemiaDr. Erba isExperienced. Learn about Anemia.
- B-Cell LymphomaDr. Erba isExperienced. Learn about B-Cell Lymphoma.